0001595336-18-000002.txt : 20180720 0001595336-18-000002.hdr.sgml : 20180720 20180720141337 ACCESSION NUMBER: 0001595336-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180720 DATE AS OF CHANGE: 20180720 EFFECTIVENESS DATE: 20180720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stemgenics, Inc. CENTRAL INDEX KEY: 0001595336 IRS NUMBER: 000000000 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-317421 FILM NUMBER: 18962217 BUSINESS ADDRESS: STREET 1: 454 N. 34TH STREET STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98103 BUSINESS PHONE: 206-676-7000 MAIL ADDRESS: STREET 1: 454 N. 34TH STREET STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98103 D 1 primary_doc.xml X0708 D LIVE 0001595336 Stemgenics, Inc. 454 N. 34TH STREET SUITE 100 SEATTLE WA WASHINGTON 98103 206-819-9433 WASHINGTON None None Corporation true Frederick S Hagen 454 N. 34th Street Suite 100 Seattle WA WASHINGTON 98103 Executive Officer Director Andranik Aprikyan 454 N. 34th Street Suite 100 Seattle WA WASHINGTON 98103 Executive Officer Director Mushegh Hovhannisyan 454 N. 34th Street Suite 100 Seattle WA WASHINGTON 98103 Executive Officer Director Anush Oganesian 454 N. 34th Street Suite 100 Seattle WA WASHINGTON 98103 Director Biotechnology Decline to Disclose 06b false 2018-06-20 false true false 0 Frederick S. Hagen None None None 454 N. 34th Street Seattle WA WASHINGTON 98103 AZ ARIZONA MN MINNESOTA ND NORTH DAKOTA WA WASHINGTON false Endeavor Capital Management Holdings None None None 1634 Lancashire Court, Apt. B Indianapolis IN INDIANA 46260 IN INDIANA false 20000000 445000 19555000 false 8 0 0 Minimum sales milestones triggering finders' fees were not met by June deadline, so no fees paid or owing thus far. 1200000 true Represents estimated salaries for executive officers over the next four years, and assumes the full amount of the offering is sold. false Stemgenics, Inc. Frederick S. Hagen, Ph.D Frederick S. Hagen Chief Executive Officer 2018-07-12